rituximab

English

Alternative forms

• IDEC-C2B8

Etymology

From [Term?] +‎ -tu- (“tumor”) +‎ -ximab (“chimeric monoclonal antibody”).

Pronunciation

• (General American) IPA^(key): /ɹɪˈtʌk.sɪˌmæb/

Noun

rituximab (usually uncountable, plural rituximabs)

1. (pharmacology) A chimeric monoclonal antibody (trademark Rituxan) administered by intravenous injection especially to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia by binding to the protein CD20 found on the surface of B cells and causing their lysis.

References

• “rituximab”, in Merriam-Webster Online Dictionary, Springfield, Mass.: Merriam-Webster, 1996–present.

Spanish

Pronunciation

• IPA^(key): /rituɡsiˈmab/ [ri.t̪uɣ̞.siˈmaβ̞]
• Rhymes: -ab
• Syllabification: ri‧tu‧xi‧mab

Noun

rituximab f (plural rituximabs)

1. (organic chemistry) rituximab